Clinical Trials Browser

Phase 3 × Not yet recruiting × pertuzumab × Clear all

NCT07441460 2026-03-02

A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer

Phase 3 Not yet recruiting

Resectable HER2-positive Breast Cancer

NCT04973319 2021-07-22

Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy

Phase 3 Not yet recruiting

Breast Neoplasms

NCT04337658 2020-04-08

FAVOR

Phase 3 Not yet recruiting

Breast Neoplasms